explore -WSS

explore

author：entertainment 2025-08-12 09:10:41 - browse：6315

By some measures, private equity investment lagged in 2023, a year marked by growing distress and high-profile downfalls among private equity-backed health care companies.

Even so, three sectors still managed to see strong deal flow and prices: med spa, cardiology, and clinical trial sites, according to a new PitchBook report analyzing private equity investments in health care services in 2023. Each of the three niches continue to generate buzz among investors, even as other areas fizzle.

It’s not that those three industries are perfect fits for private equity, it’s that the more obvious areas like autism therapists and physician practices are struggling with high interest rates and regulatory scrutiny, said Rebecca Springer, PitchBook’s lead health care analyst.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Senate panel eyes new effort on drug shortages

knowledge

WSS

Hospitals are piloting generative AI tools as regulators play catch

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

MD Anderson's Padmanee Sharma responds to research credit suit

Colorectal cancer study finds potential in overlooked immune cell

Why age limits for politicians are a terrible idea

Why Charlie Gard's case is so disturbing to Americans

knowledge

explore

focus

Continuity nursing helped my family in our darkest PICU moments

3 questions for the future of Biden's cancer moonshot

DIEP, the 'gold standard' of breast reconstruction, is under threat

A new drug could help frostbite victims avoid its ravages

How one medical school became remarkably diverse

Weight loss drugs aren’t covered by Obamacare. That may change

Alkermes shareholders re

Was Amgen transparent enough on FDA's concern on cancer drug?

DIEP, the 'gold standard' of breast reconstruction, is under threat

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

hotspot

Stroke deaths set to near 10 million globally by 2050

Secretariat’s lessons for human medicine

Chan Zuckerberg Biohub Chicago to focus on inflammation

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

Chan Zuckerberg Biohub Chicago to focus on inflammation

Ukraine seeks to reclaim its role as a hub for clinical trials

explore

knowledge

hotspot

entertainment